Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Lisata Therapeutics, Inc. (LSTA) had Non-Operating Income/Expense of $0.21M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.07M |
|
$-4.66M |
|
-- |
|
$0.07M |
|
$4.94M |
|
$-4.87M |
|
|
Non-Operating Income/Expense |
$0.21M |
$-4.66M |
|
$-4.66M |
|
$-4.66M |
|
$-4.66M |
|
$-4.66M |
|
$-4.66M |
|
$-4.87M |
|
$-4.84M |
|
8.61M |
|
8.61M |
|
$-0.54 |
|
$-0.54 |
|
| Balance Sheet Financials | |
$24.89M |
|
$0.05M |
|
$0.28M |
|
$25.16M |
|
$4.31M |
|
-- |
|
$0.07M |
|
$4.38M |
|
$20.77M |
|
$20.62M |
|
$20.77M |
|
8.63M |
|
| Cash Flow Statement Financials | |
$-9.36M |
|
$9.94M |
|
$0.04M |
|
$16.21M |
|
$16.84M |
|
$0.63M |
|
$0.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.77 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-6954.28% |
|
-6954.28% |
|
-- |
|
-6655.71% |
|
-6655.71% |
|
$-9.39M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.14 |
|
644.14 |
|
-22.43% |
|
-22.60% |
|
-18.52% |
|
-22.43% |
|
$2.41 |
|
$-1.09 |
|
$-1.09 |
|